The role of endothelial cells in the resolution of acute inflammation

Antioxidants and Redox Signaling

Volumn 7, Issue 11-12, 2005, Pages 1744-1754

  Kadl, Alexandra ^a   Leitinger, Norbert ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANGIOPOIETIN 1; CD39 ANTIGEN; CELL ADHESION MOLECULE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE SPECIFIC PROTEIN 1; LIPOPOLYSACCHARIDE; LIPOXIN; NITRIC OXIDE SYNTHASE; PEPTIDOLEUKOTRIENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROSTAGLANDIN D2; REACTIVE OXYGEN METABOLITE; RESOLVIN; SPHINGOSINE 1 PHOSPHATE; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; BLOOD VESSEL; CELL ADHESION; CELL MIGRATION; CHRONIC DISEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; STEADY STATE; TISSUE INJURY; TISSUE REGENERATION; WOUND HEALING;

ACUTE DISEASE; ANIMALS; CELL ADHESION; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LEUKOCYTES; LIPID METABOLISM;

EID: 28844495011     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1744     Document Type: Short Survey

References (112)

1. Ariel A, Chiang N, Arita M, Petasis NA, and Serhan CN. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J Immunol 170: 6266-6272, 2003.
2. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, and Serhan CN. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201: 713-722, 2005.
3. Arruda MA, Rossi AG, de Freitas MS, Barja-Fidalgo C, and Graca-Souza AV Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-kappaB. J Immunol 173: 2023-2030, 2004.
4. Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C, and Staels B. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arteriosder Thromb Vasc Biol 22: 717-726, 2002.
5. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, and FitzGerald GA. Biosynthesis of 15-deoxy-deltal2,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 112: 945-955, 2003.
6. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, Verin AD, Bokoch GM, Leitinger N, and Garcia JG. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 95: 892-901, 2004.
7. Bochkov VN, Kadi A, Huber J, Gruber F, Binder BR, and Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 419: 77-81, 2002.
8. Brigelius-Flohe R, Banning A, and Schnurr K. Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 5: 205-215, 2003.
9. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, and Scares MP. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 277: 17950-17961, 2002.
10. Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, and Cirino G. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA 102: 904-908, 2005.
11. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di CF, Haskard DO, and Mason JC. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766, 2004.
12. Chang MK, Bergmark C, Laurila A, Horkko S, Han KH, Friedman P, Dennis EA, and Witztum JL. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 96: 6353-6358, 1999.
13. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, Berliner JA, and Witztum JL. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 200: 1359-1370, 2004.
14. Connelly L, Madhani M, and Hobbs AJ. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived NO in vivo. J Biol Chem 280: 10040-10046, 2005.
15. Davenpeck KL, Gauthier TW, and Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994.
16. Davi G, Falco A, and Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 7: 256-268, 2005.
17. Daynes RA and Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2: 748-759, 2002.
18. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, and Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1995.
19. Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K, and Serhan CN. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17: 652-659, 2003.
20. Didion SP, Kinzenbaw DA, Fegan PE, Didion LA, and Faraci FM. Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke 35: 1963-1967, 2004.
21. Dudek SM and Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
22. Dulak J, Jozkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, and Motterlini R. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4: 229-240, 2002.
23. Eltzschig HK, Ibla JC, Furuta GT, Leonard MO, Jacobson KA, Enjyoji K, Robson SC, and Colgan SP. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198: 783-796, 2003.
24. 1+ signaling and NO production in endothelial cells. Antioxid Redox Signal 5: 147-153, 2003.
25. Furchgott RF and Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
26. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, and Vadas MA. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87: 603-607, 2000.
27. Gilroy DW, Tomlinson A, and Willoughby DA. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res 47: 79-85, 1998.
28. Gilroy DW, Tomlinson A, and Willoughby DA. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur J Pharmacol 355: 211-217, 1998.
29. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, and Willoughby DA. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701, 1999.
30. Gilroy DW, Colville-Nash PR, McMaster S, Sawatzky DA, Willoughby DA, and Lawrence T. Inducible cyclooxyge-nase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J 17: 2269-2271, 2003.
31. Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, and Croxtall JD. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J 18: 489-98, 2004.
32. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, and Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164: 1663-1667, 2000.
33. Goepfert C, Imai M, Brouard S, Csizmadia E, Kaczmarek E, and Robson SC. CD39 modulates endothelial cell activation and apoptosis. Mol Med 6: 591-603, 2000.
34. Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, and Serhan CN. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am J Pathol 158: 3-9, 2001.
35. Guckelberger O, Sun XF, Sevigny J, Imai M, Kaczmarek E, Enjyoji K, Kruskal JB, and Robson SC. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohy-drolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost 91: 576-586, 2004.
36. 2,-induced endothelial barrier dysfunction: mechanisms of protection. Am J Physiol Lung Cell Mol Physiol 280: L116-L126, 2001.
37. Hayashi S, Takamiya R, Yamaguchi T, Matsumoto K, Tojo SJ, Tamatani T, Kitajima M, Makino N, Ishimura Y, and Suematsu M. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85: 663-671, 1999.
38. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Sevan JA, and Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 311: 239-242, 1995.
39. Huber J, Vales A, Mitulovic G, Blumer M, Schmid R, Witztum JL, Binder BR, and Leitinger N. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 22: 101-107, 2002.
40. Huber J, Bochkov VN, Binder BR, and Leitinger N. The isoprostane 8-iso-PGE2 stimulates endothelial cells to bind monocytes via cyclic AMP- and p38 MAP kinase-dependent signaling pathways. Antioxid Redox Signal 5: 163-169, 2003.
41. Imai M, Goepfert C, Kaczmarek E, and Robson SC. CD39 modulates IL-I release from activated endothelial cells. Biochem Biophys Res Commun 270: 272-278, 2000.
42. Ishikawa K, Navab M, Leitinger N, Fogelman AM, and Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216, 1997.
43. Jackson JR, Seed MP, Kircher CH, Willoughby DA, and Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 11: 457-65, 1997.
44. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, Alcami A, Lira SA, Wiekowski M, and Graham GJ. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 6: 403-11, 2005.
45. Jongstra-Bilen J, Misener VL, Wang C, Ginzberg H, Auerbach A, Joyner AL, Downey GP, and Jongstra J. LSPl modulates leukocyte populations in resting and inflamed peritoneum. Blood 96: 1827-1835, 2000.
46. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angio-genic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
47. Jozsef L, Zouki C, Petasis NA, Serhan CN, and Filep JG. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-I activation, and IL-8 gene expression in human leukocytes. Proc Natl Acad Sci USA 99: 13266-13271, 2002.
48. Kadi A, Huber J, Gruber F, Bochkov VN, Binder BR, and Leitinger N. Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul Pharmacol 38: 219-227,2002.
49. Kadi A, Bochkov VN, Huber J, and Leitinger N. Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid Redox Signal 6: 311-320, 2004.
50. Kagan VE, Borisenko GG, Serinkan BF, Tyurina YY, Tyurin VA, Jiang J, Liu SX, Shvedova AA, Fabisiak JP, Uthaisang W, and Fadeel B. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine. Am J Physiol Lung Cell Mol Physiol 285: L1-L17, 2003.
51. Kawa S, Kimura S, Hakomori S, and Igarashi Y Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett 420: 196-200, 1997.
52. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
53. Koskinen K, Vainio PJ, Smith DJ, Pihlavisto M, YIl-Herttuala S, Jalkanen S, and Salmi M. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-I). Blood 103: 3388-3395, 2004.
54. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadi A, Binder BR, and Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 278: 51006-51014, 2003.
55. Kudo I and Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68-69: 3-58, 2002.
56. Kushida T, Li VG, Quan S, Goodman A, and Abraham NG. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem 87: 377-385, 2002.
57. Lawrence T, Gilroy DW, Colville-Nash PR, and Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 1: 1291-1297, 2001.
58. Lawrence T, Willoughby DA, and Gilroy DW. Anti-inflamatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 1: 787-795, 2002.
59. Lefer DJ, Scalia R, Campbell B, Nossuli T, Hayward R, Salamon M, Grayson J, and Lefer AM. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 99: 684-691, 1997.
60. Lefer DJ, Jones SP, Girod WG, Baines A, Grisham MB, Cockrell AS, Huang PL, and Scalia R. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 276: H1943-H1950, 1999.
61. Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, and Vora DK. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci USA 96: 12010-12015, 1999.
62. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, and Serhan CN. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8: 1018-1023, 2002.
63. Lin SJ, Shyue SK, Hung YY, Chen YH, Ku HH, Chen JW, Tam KJB, and Chen YL. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intra-cellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 25: 334-340, 2005.
64. Liu L, Cara DC, Kaur J, Raharjo E, Mullaly SC, Jongstra-Bilen J, Jongstra J, and Kubes P. LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J Exp Med 201: 409-18, 2005.
65. Marx N, Duez H, Fruchart JC, and Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94: 1168-1178, 2004.
66. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, and Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 170: 987-993, 2004.
67. Middleton J, Patterson AM, Gardner L, Schmutz C, and Ashton BA. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 100: 3853-3860, 2002.
68. 2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression. Arterioscler Thromb Vasc Biol 25: 710-716, 2005.
69. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, and Takashima A. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8: 358-365, 2002.
70. Moncure M, Chen L, Childs EW, Smalley D, Udobi KF, and Cheung LY. Heme-oxygenase-1 mRNA expression affects hemorrhagic shock-induced leukocyte adherence. J Trauma 55: 118-125, 2003.
71. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T, Otterbein SL, Otterbein LE, and Choi AM. Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278: 36993-36998, 2003.
72. Nossuli TO, Hayward R, Scalia R, and Lefer AM. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation 96: 2317-2324, 1997.
73. Nossuli TO, Hayward R, Jensen D, Scalia R, and Lefer AM. Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol 275: H509-H519, 1998.
74. O'Donnell VB. Free radicals and lipid signaling in endothelial cells. Antioxid Redox Signal 5: 195-203, 2003.
75. Otterbein LE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 4: 309-319, 2002.
76. Otterbein LE, Bach FH, Alam J, Soares M, Tao LH, Wysk M, Davis RJ, Flavell RA, and Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
77. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, and Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169: 1245-1251, 2004.
78. Pizurki L, Zhou Z, Glynos K, Roussos C, and Papapetropoulos A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139: 329-336, 2003.
79. Pontsler AV, St Hilaire A, Marathe GK, Zimmerman GA, and McIntyre TM. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J Biol Chem 277: 13029-13036, 2002.
80. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, and Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-257, 1990.
81. Rueckschloss U, Duerrschmidt N, and Morawietz H. NADPH oxidase in endothelial cells: impact on atherosclerosis. Antioxid Redox Signal 5: 171-180, 2003.
82. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 61: 375-380, 1997.
83. Savill J and Haslett C. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 6: 385-393, 1995.
84. Schaphorst KL, Chiang E, Jacobs KN, Zaiman A, Natarajan V, Wigley F, and Garcia JG. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 285: L258-L267, 2003.
85. Scher JU and Pillinger MH. 15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol 114: 100-109, 2005.
86. Schopfer FJ, Lin Y, Baker PR, Cui T, Garcia-Barrio M, Zhang J, Chen K, Chen YE, and Freeman BA. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci USA 102: 2340-2345, 2005.
87. Serhan CN. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 122: 305-321, 2004.
88. Serhan CN and Chiang N. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. ScientificWorldJournal 2: 169-204, 2002.
89. Serhan CN and Levy B. Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem Immunol Allergy 83: 115-145, 2003.
90. Serhan CN, Takano T, Clish CB, Gronert K, and Petasis N. Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogs inhibit neutrophil-mediated changes in vascular permeability. Adv Exp Med Biol 469: 287-293, 1999.
91. Serhan CN, Gotlinger K, Hong S, and Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 11: 155-172, 2004.
92. Shih PT, Elices MJ, Fang ZT, Ugarova TP, Strahl D, Territo MC, Frank JS, Kovach NL, Cabanas C, Berliner JA, and Vora DK. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. J Clin Invest 103: 613-625, 1999.
93. Soares MP, Usheva A, Brouard S, Berberat PO, Gunther L, Tobiasch E, and Bach FH. Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. Antioxid Redox Signal 4: 321-329, 2002.
94. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, and Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172: 3553-3563, 2004.
95. Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hanninen A, Jalkanen S, and Salmi M. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity 22: 105-115, 2005.
96. Stone PC, Lally F, Rahman M, Smith E, Buckley CD, Nash GB, and Rainger GE. Transmigrated neutrophils down-regulate the expression of VCAM-1 on endothelial cells and inhibit the adhesion of flowing lymphocytes. J Leukoc Biol 77: 44-51, 2005.
97. Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, and Berliner JA. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta. J Biol Chem 277: 7271-7281, 2002.
98. Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, and Serhan CN. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185: 1693-1704, 1997.
99. Thomas SR, Chen K, and Keaney JF Jr. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal 5: 181-194, 2003.
100. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, and McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514, 1999.
101. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, and Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463, 2000.
102. Tohka S, Laukkanen M, Jalkanen S, and Salmi M. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J 15: 373-382, 2001.
103. Varadhachary AS, Monestier M, and Salgame P. Reciprocal induction of IL-10 and IL-12 from macrophages by low-density lipoprotein and its oxidized forms. Cell Immunol 213: 45-51, 2001.
104. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, and Pritchard KA Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 95: 9220-9225, 1998.
105. Wakai A, Wang JH, Winter DC, Street JT, O'Sullivan RG, and Redmond HP. Adenosine inhibits neutrophil vascular endothelial growth factor release and transendothelial migration via A2B receptor activation. Shock 15: 297-301, 2001.
106. Wang C, Hayashi H, Harrison R, Chiu B, Chan JR, Ostergaard HL, Inman RD, Jongstra J, Cybulsky MI, and Jongstra-Bilen J. Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis. J Immunol 169: 415-423, 2002.
107. Willis D, Moore AR, Frederick R, and Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87-90, 1996.
108. Willis D, Moore AR, and Willoughby DA. Heme oxygenase isoform expression in cellular and antibody-mediated models of acute inflammation in the rat. J Pathol 190: 627-634, 2000.
109. Willoughby DA, Moore AR, Colville-Nash PR, and Gilroy D. Resolution of inflammation. Int J Immunopharmacol 22: 1131-1135, 2000.
110. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, and Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111: 97-105, 2005.
111. Wong D, Dorovini-Zis K, and Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 190: 446-455, 2004.
112. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248-1258, 2003.